Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.96B | 13.31B | 14.29B | 15.20B | 15.96B | Gross Profit |
5.85B | 6.08B | 6.62B | 7.39B | 7.48B | EBIT |
-3.81M | -46.32M | 155.04M | 689.61M | 922.55M | EBITDA |
-282.40M | 326.69M | 501.36M | 1.00B | 1.18B | Net Income Common Stockholders |
-689.81M | -15.16M | 111.70M | 466.55M | 560.44M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.48B | 6.79B | 5.73B | 7.06B | 6.79B | Total Assets |
15.07B | 16.26B | 16.44B | 16.74B | 17.11B | Total Debt |
6.64B | 6.83B | 6.99B | 7.12B | 7.39B | Net Debt |
154.94M | 40.40M | 1.26B | 61.13M | 599.16M | Total Liabilities |
8.51B | 8.91B | 8.99B | 9.32B | 10.02B | Stockholders Equity |
6.56B | 7.36B | 7.45B | 7.42B | 7.10B |
Cash Flow | Free Cash Flow | |||
34.94M | 1.37B | -1.05B | 672.69M | 1.19B | Operating Cash Flow |
162.15M | 1.43B | -899.44M | 741.38M | 1.30B | Investing Cash Flow |
212.00K | -890.77M | 746.81M | -36.55M | -714.12M | Financing Cash Flow |
-342.49M | -305.95M | -268.85M | -401.78M | -472.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥3.30B | 9.99 | 1.11% | 16.08% | -9.31% | ||
70 Outperform | ¥4.17B | 12.47 | 1.69% | 4.34% | 63.23% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
62 Neutral | ¥5.03B | 15.71 | 3.39% | -10.86% | -28.97% | ||
56 Neutral | ¥3.38B | ― | ― | 7.71% | -843.03% | ||
47 Neutral | ¥4.15B | 262.06 | 2.35% | -2.66% | -4452.83% |